Milestone for Cardiff anti-shingles drug
16/12/2010
Pharmaceutical company Inhibitex Inc has reported promising results from the phase 2 trial of FV-100, the anti-shingles drug developed in collaboration with Professor Chris McGuigan's research group at Cardiff University.